Friday, May 20, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

BARDA Seeks Applications for Developing At-Home COVID-19 Diagnostics and Technologies

by Global Biodefense Staff
October 20, 2021
BARDA Seeks Applications for Developing At-Home COVID-19 Diagnostics and Technologies

Courtesy of BARDA

The U.S. Government program is now accepting submissions to develop diagnostics to detect SARS-CoV-2 acute infection as part of a new “COVID-19 At Home Diagnostics” program.

The Biomedical Advanced Research and Development Authority (BARDA) has opened a new area of interest under the EZ Broad Agency Announcement (EZ-BAA) solicitation to develop rapid and affordable home-based diagnostics to detect SARS-CoV-2 acute infection and supportive technologies which help enable more widespread, decentralized testing.

At-home diagnostics can empower individuals with better knowledge about their infection status, and ultimately reduce community transmission.

Through this opportunity, BARDA aims to advance the maturity of simpler tests that are inexpensive and easy to use. For more advanced tests, BARDA anticipates achievement of U.S. Food and Drug Administration (FDA) Emergency Use Authorization within six months. The ideal candidates would leverage existing manufacturing capabilities and be available to the public through the over-the-counter market.

BARDA is also seeking technologies that enable more convenient, widespread, and decentralized COVID-19 testing, or that improve on the current limitations of at-home diagnostic sensitivity, specificity and performance.

Early on during the pandemic, BARDA accepted applications through the EZ-BAA for COVID-19 antigen and molecular tests, which led to approximately 30 partnerships, 26 EUAs, and 140 million tests shipped. Reducing the barrier to testing is critical to equipping individuals with actionable health information when COVID-19 symptoms first occur so that they can self-isolate and seek medical care, thus helping to suppress the pandemic curve.

The initiative is sponsored by BARDA’s Divisions of Research, Innovation, and Ventures (DRIVe) and Detection, Diagnostics, and Devices Infrastructure (DDDI).

For additional information, see solicitation AOIs 11A: Home-based, Over-the-Counter Diagnostics for the Detection of SARS CoV-2 and 11B: Enabling Technologies to Support Home-Based Diagnostics for SARS-CoV-2 Acute Infection in the Special Instructions 014 Issuance of the EZ-BAA (BAA-20-100-SOL-0002). Abstracts may be submitted until 5:00PM ET on January 15, 2022.

Tags: BAABARDACOVID-19Editor PickRapid DiagnosticsRequest for ProposalsSARS-CoV-2

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools
Biodetection

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Yersinia pestis
Funding News

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

April 8, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC